Depression and anxiety affect up to 50% of people with Parkinson's Disease (PD) (Marsh, 2000; Murray, 1996), however, few studies have examined the effectiveness of psychological treatment. This study examined the effectiveness of group cognitive behaviour therapy (CBT) in treating depression and anxiety in PD. Four participants, aged between 56 and 81 years, who had been diagnosed with PD and suffering from depression and/or anxiety were included in the study. The results suggested that CBT was effective in treating depression and anxiety in PD. Furthermore, the results supported that the gains were maintained at 1-month follow-up
A significant proportion of persons affected by Parkinson’s disease (PD) are over age 65 years. Ment...
Background: Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have ...
Parkinson's disease (PD) is associated with significant symptoms of depression. Cognitive behaviour ...
Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatme...
Nonpharmacological therapies, like cognitive behavioral therapy (CBT), for the treatment of non-moto...
Parkinson's disease [PD] is a heterogeneous neurological disorder that is characterized by motor and...
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Ther...
Background Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes i...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
Parkinson's disease (PD) is characterized by motor symptoms, but nonmotor symptoms also significantl...
AbstractBackgroundParkinson's disease (PD) is often associated with depression and anxiety. The avai...
OBJECTIVES: Anxiety is a prevalent but understudied non-motor symptom of Parkinson’s disease (PD), f...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)The purpose of this study was to...
Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact ...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
A significant proportion of persons affected by Parkinson’s disease (PD) are over age 65 years. Ment...
Background: Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have ...
Parkinson's disease (PD) is associated with significant symptoms of depression. Cognitive behaviour ...
Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatme...
Nonpharmacological therapies, like cognitive behavioral therapy (CBT), for the treatment of non-moto...
Parkinson's disease [PD] is a heterogeneous neurological disorder that is characterized by motor and...
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Ther...
Background Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes i...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
Parkinson's disease (PD) is characterized by motor symptoms, but nonmotor symptoms also significantl...
AbstractBackgroundParkinson's disease (PD) is often associated with depression and anxiety. The avai...
OBJECTIVES: Anxiety is a prevalent but understudied non-motor symptom of Parkinson’s disease (PD), f...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)The purpose of this study was to...
Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact ...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
A significant proportion of persons affected by Parkinson’s disease (PD) are over age 65 years. Ment...
Background: Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have ...
Parkinson's disease (PD) is associated with significant symptoms of depression. Cognitive behaviour ...